The Best Dividend Stocks To Buy In January 2022

Looking for the best dividend stocks to buy in January 2022? In my opinion, these are a few must-have dividend stocks to buy right now, and are some of the ones I am considering purchasing for my dividend stock portfolio throughout the month of January 2022.

In this video, we'll be discussing a handful of dividend stocks to buy that are currently at a discount, and are what I think some of the best dividend stocks to add to your dividend stock portfolio in January 2022 to increase your passive dividend income, and these dividend stocks include TGT, BBY, LEG, and EPD... Let's get into it!

📢 If you enjoyed watching this video, I kindly ask you to consider leaving a THUMBS UP on this video. If you're interested in seeing more dividend content from me, including monthly dividend portfolio updates, dividend stock analyses, dividend investing tips/tricks/how-to's, and videos on the best dividend stocks to buy right now, please consider SUBSCRIBING to the channel! I appreciate all of your support, and would love to have each and every one of you follow along on my dividend investing journey. 📢

💬 JOIN THE FREE DIVIDEND STOCK DISCORD SERVER 💬 ►   / discord  
📺 SUBSCRIBE To The Channel 📺 ► https://www.youtube.com/channel/UC4SK...
💬 FOLLOW Me On Instagram 💬 ►   / rynewilliams  
📈FREE Dividend Portfolio Tracker (v4.0) 📈 ► https://docs.google.com/spreadsheets/...
📝FREE Guide On How To Analyze Dividend Stocks For Beginners 📝 ► https://docs.google.com/document/d/1v...

⏰ TIMESTAMPS ⏰
0:00​​ - Intro
1:07 - Reviewing Last Month’s Picks
2:30 - Stock #1 (EPD)
9:59 - Stock #2 (TGT)
15:28 - Stock #3 (LEG)
21:34 - Stock #4 (BBY)
26:01 - Conclusion

#dividendstocks #dividendinvesting #bestdividendstocks #dividendportfolio #dividends #dividendkings

The ideas and opinions presented in this video are meant for informational and entertainment purposes only, are not intended to serve as a recommendation to buy or sell any security in any account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision.